Metformin × adverse events & safety

SynthesisArchives of endocrinology and metabolism2019

Efficacy and safety of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes mellitus with inadequate glycemic control on metformin: a meta-analysis.

Zhang Jingfan et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedrandomised · 2019

Randomised comparison

Probably raised adverse events & safety

2.4× to 6.7×

Bigger than 9 in 10 for adverse events & safety

As reported

RR 3.98, 95% CI 2.38–6.67

One number in the abstract

the abstract, start to end

higher risk of genital infection [RR = 3.98, 95% CI (2.38, 6.67), p <

← favours treatmentfavours comparator →
could be chance
Adverse events & safety
RR 3.982.38–6.67
MetforminAdverse events & safety
1 / 3

10 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 31271575